首页 | 本学科首页   官方微博 | 高级检索  
检索        

美沙拉嗪联合培菲康治疗溃疡性结肠炎的临床疗效分析
引用本文:麦哲林.美沙拉嗪联合培菲康治疗溃疡性结肠炎的临床疗效分析[J].中国医药指南,2013,0(22):15-16.
作者姓名:麦哲林
作者单位:麦哲林 (广东省鹤山市人民医院消化内科,广东 江门,529700);
摘    要:目的探讨美沙拉嗪联合培菲康治疗溃疡性结肠炎的临床疗效。方法选取我院2005年-2012年80例溃疡性结肠炎患者的资料,根据其治疗方式分为观察组和治疗组,各40例,两组均应用美沙拉嗪治疗,观察组患者加用培菲康,随访8周,对两组患者治疗效果进行评价。结果观察组患者治疗效果好,与对照组患者比较差异有统计学意义(P<0.05)。结论美沙拉嗪联合培菲康治疗溃疡性结肠炎,能降低炎性反应,提高治疗效果,值得在临床推广。

关 键 词:美沙拉嗪  培菲康  溃疡性结肠炎  临床疗效

the Clinical Eftlcacy of Mesalazine Treatment of Joint Bifico Analysis of Ulcerative Colitis
MAI Zhe-lin.the Clinical Eftlcacy of Mesalazine Treatment of Joint Bifico Analysis of Ulcerative Colitis[J].Guide of China Medicine,2013,0(22):15-16.
Authors:MAI Zhe-lin
Institution:MAI Zhe-lin (Department of Gastroenterology, Heshan People's Hospital, Jiangmen 529700, China)
Abstract:Ohjeetive To investigate the clinical efficacy the of Mesalazine joint Bifico the treatment of ulcerative colitis. Methods Our hospital from 2005 to 2012, 80 patients with ulcerative colitis patients, divided into observation group and a treatment group based on.their treatment, 40 patients in both groups applied mesalazine treatment, patients of the observation group and with Bifico followed for 8 weeks to evaluate the therapeutic effect of two groups of patients. Results The patient outcomes compared with the control group of patients was statistically significant (P〈0.05) difference. Conclusion The of mesalazine joint Bifico the treatment of ulcerative colitis, can reduce the inflammatory response, improvetreatment, worth in clinical practice.
Keywords:Mesalazine triazine  Bifico  Ulcerative colitis  Clinical efficacy
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号